Enhanced IL-4 Production and IL-4 Receptor Expression in Atopic Dermatitis and Their Modulation by Interferon-Gamma
- 1 October 1992
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 99 (4), 403-408
- https://doi.org/10.1111/1523-1747.ep12616114
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Evidence suggesting involvement of interleukin-4 (IL-4) production in spontaneous in vitro IgE synthesis in patients with atopic dermatitisJournal of Allergy and Clinical Immunology, 1991
- 383 Recombinant interferon-gamma (rIFN-γ) therapy reduces the clinical severity of atopic dermatitis (AD)Journal of Allergy and Clinical Immunology, 1991
- 381 Decreased gamma interferon(IFN-γ) and increased interleukin-4 (IL-4) in atopic dermatitis(AD)Journal of Allergy and Clinical Immunology, 1991
- Structure and expression of germline epsilon transcripts in human B cells induced by interleukin 4 to switch to IgE production.The Journal of Experimental Medicine, 1990
- Evidence that defective interferon-gamma production in dermatitis patients is due to intrinsic abnormalitiesClinical and Experimental Immunology, 1990
- Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon‐γEuropean Journal of Immunology, 1990
- Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells.The Journal of Experimental Medicine, 1989
- Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures.The Journal of Experimental Medicine, 1988
- Characterization of the human B cell stimulatory factor 1 receptor.The Journal of Experimental Medicine, 1987
- Interferon-γ and B Cell Stimulatory Factor-1 Reciprocally Regulate Ig Isotype ProductionScience, 1987